Media & news

From the CEO

by: Richard Laube CEOFebruary 23, 2013

When it comes to patients, there is no compromising our standards.

Nobel Biocare spends 10% of its sales revenue on Research and Development (R&D). That percentage is higher than anyone else’s in the industry. Much of this investment goes to design, develop and produce new and innovative products and solutions that help you treat more patients better every day.

An increasingly large portion of this R&D investment is also used to technically test and clinically validate Nobel Biocare’s implants and solutions, ensuring they are safe, predictable and perform as designed. In addition, we have significantly increased investment in our manufacturing quality management systems.

We do everything possible to ensure our products are produced to the most exacting standards every time. Knowing all of the effort and investment needed to develop and produce a safe and predictable product according to high industry standards, it is difficult to understand why any clinician would purchase an implant or restorative component that may remain in a patient’s mouth for decades from a company that does not provide similar evidence.

When it comes to patients, there is no compromising our standards. This is why we are so committed to evidence-based dentistry.